LVIVO-TaVec100
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LVIVO-TaVec100, covering 2025-08-12 to 2025-08-12. Get the full timeline:
Most recent: Clinical Trial Update: The LVIVO-TaVec100 Product in the Treatment of Relapsed/Refractory B-cell Malignancies [Phase 1]